(RTTNews) - German pharmaceutical and life sciences major Bayer AG (BAYZF.PK, BAYRY.PK, BYR.L) announced Thursday that its clinical stage cell therapy unit BlueRock Therapeutics LP's investigational cell therapy bemdaneprocel to treat Parkinson's disease has received the U.S. Food and Drug Administration's Regenerative Medicine Advanced Therapy or RMAT designation.
Bayer Subsidiary Gets Fast-track Status f... - Cure Parkinson's
Bayer Subsidiary Gets Fast-track Status for Parkinson's Treatment in U.S.
As described in Section 3033 of the 21st Century Cures Act, a drug is eligible for regenerative medicine advanced therapy (RMAT) designation if:
The drug is a regenerative medicine therapy, which is defined as a cell therapy, therapeutic tissue engineering product, human cell and tissue product, or any combination product using such therapies or products, except for those regulated solely under Section 361 of the Public Health Service Act and part 1271 of Title 21, Code of Federal Regulations;
The drug is intended to treat, modify, reverse, or cure a serious or life-threatening disease or condition; and
Preliminary clinical evidence indicates that the drug has the potential to address unmet medical needs for such disease or condition
So now the company that poisons us has a "cure"?!
Yes; how, when and where did that happen?
I think he is pointing out about the pesticides which Bayer used to manufacture earlier
"used to"? Bayer is round up no?
Bayer is Roundup and Paraquat, I believe
Paraquat is a fast track to guaranteed Parkinson's if you get it in you...my opinion. Widespread use in the USA has gone up rather than down.